H-beta-tBu-DL-Ala-OH

H-beta-tBu-DL-Ala-OH is a β-substituted alanine derivative bearing a tert-butyl group at the β-position and a free carboxylic acid, with a DL stereochemical description indicating racemic material at the chiral center. The structure retains the amino acid core functionality suitable for peptide chemistry while introducing increased steric bulk that can influence conformational preference, coupling efficiency, and side-chain reactivity in downstream transformations. The free acid enables direct participation in amide bond formation after activation, while the β-tert-butyl substituent provides a handle for stereochemical and steric effects in structure-property studies. The compound is commonly handled as a chiral amino acid intermediate or protected amino acid precursor in synthetic sequences that require controlled incorporation of β-substituted alanine motifs into peptides and peptidomimetics.

1. Peptide Synthesis

H-beta-tBu-DL-Ala-OH supports peptide coupling workflows where the carboxylic acid is activated to form an amide linkage to an appropriately protected amino group. The β-tert-butyl substituent functions as a steric modulator that can be used to probe backbone substitution effects, influence local secondary structure, and generate β-substituted alanine residues within peptide building block sets. Incorporation into peptide chains typically requires N-protection and may also involve C-terminal activation strategies compatible with standard peptide coupling reagents. The resulting β-substituted peptide analogs can be used to generate libraries for SAR studies and to benchmark synthesis conditions for hindered amino acid residues in solid-phase or solution-phase peptide assembly.

2. Peptidomimetics And SAR Studies

H-beta-tBu-DL-Ala-OH is applicable to peptidomimetic design where β-substitution with a tert-butyl group creates steric constraints that can alter conformational ensembles and receptor-binding surface presentation. The amino acid framework provides a recognizable scaffold for medicinal chemistry programs that translate amino acid stereochemistry and spacing into non-natural backbone features. The free carboxylic acid can be converted into amide, ester, or activated acid derivatives to support rapid derivatization of analog series and to enable systematic side-chain variation around a β-tert-butyl motif. Downstream use includes preparing SAR-focused analogs, fragment-like peptide surrogates, and constrained building blocks for structure-activity relationship investigations.

3. Chiral Building Block Development

H-beta-tBu-DL-Ala-OH serves as a chiral amino acid intermediate starting point for routes that separate enantiomers or convert the racemate into stereochemically defined derivatives. The presence of a single stereogenic center adjacent to the amino acid backbone makes the compound suitable for stereochemical control strategies such as resolution, chiral derivatization, or enantiomer-selective downstream transformations. The β-tert-butyl group helps differentiate conformers and can be leveraged to improve selectivity in certain separation or derivatization schemes by increasing steric discrimination. The resulting enantiopure β-substituted alanine derivatives can then be used as protected amino acid building blocks for stereochemically defined peptide construction and chiral synthetic methodology development.

4. Amino Acid Derivatization

H-beta-tBu-DL-Ala-OH can undergo functional group transformations at the carboxylate to yield activated acids, esters, or amide derivatives that feed directly into synthetic organic chemistry sequences. The β-tert-butyl substituent provides a stable hydrophobic steric element that can be retained through many derivatization steps, enabling consistent SAR-style comparisons across multiple functionalized analogs. Conversion to protected amino acid forms supports N-terminal coupling chemistry, while selective esterification or amidation can generate intermediates for downstream conjugation and scaffold diversification. The compound thus functions as a practical amino acid-based intermediate for producing β-substituted derivatives used in library synthesis, process development studies, and fine chemical manufacturing of amino acid-derived intermediates.

5. Pharmaceutical Intermediate Preparation

H-beta-tBu-DL-Ala-OH is suitable for pharmaceutical intermediate preparation where β-substituted amino acid motifs are incorporated into peptidic or peptidomimetic intermediates during process chemistry. The free carboxylic acid enables controlled activation to form coupling-ready species, while the amino acid backbone supports standard protection/deprotection logic used in manufacturing-compatible peptide synthesis. The tert-butyl β-substituent can be used to tune steric profiles and improve reproducibility of intermediate profiles in multi-step syntheses that require consistent handling of hindered residues. Downstream utility includes producing well-defined amino acid building blocks for scale-up routes, intermediate purification development, and robust synthesis planning for complex peptide-like structures.

1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

2. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

4. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

5. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes